SynthesisFrontiers in public health2022

Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review.

Jinyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.